Endocrinology Flashcards
What levels of HbA1c and glucose are diagnostic for diabetes?
HbA1c >48
Random glucose >11
Fasting glucose >7
Medical management of type II diabetes
1st line - metformin
2nd line (if HbAa1c >58) - add 2nd drug from other diabetes drugs
3rd line - (if HbA1c remains above 58) - consider insulin therapy
Name the most common sulphonylurea medication and it’s mechanism of action
Gliclazide
Increases insulin release from pancreas
Name the common thiazolidinedione and its MOA
Pioglitazone
Increases insulin sensitivity
Name the common SGLT2-inhibitors
Empagliflozin, canagliflozin, dapagliflozin
Name the common DDP4 inhibitor and it’s MOA
Sitagliptin
Inhibits breakdown of GLP-1 (which in turn stimulates insulin release)
Name the common GLP-1 Mimetic
Exenatide
Which diabetes medication class increases the risk of bladder cancer
Thiazolidinediones e.g, pioglitazone
Which diabetes medication is contraindicated in patients with heart failure?
Thiazolidinediones e.g, pioglitazone
Which diabetes medication class increase the risk of fournier’s gangrene?
SGLT-2 inhibitors e.g, empagliflozin
Which diabetes medication is preferable in patients who are overweight
DPP4 inhibitors e.g, sitagliptin
Pathophysiology of hyperosmolar hyperglycaemic state (HHS)
Hyperglycaemia leads to osmotic diuresis with associated loss of sodium and potassium
Severe volume depletion leads to raised serum osmolarity
Hyperviscosity of blood can lead to vascular complications
Clinical features of Hyperosmolar hyperglycaemic state (HHS)
Nausea, vomiting
Polydipsia
Neurological symptoms e.g, reduced GSC, headaches, weakness
Cardiovascular symptoms - hypotension, tachycardia
Significantly raised serum osmolarity
Hypovolemic
Hyperglycaemic (>30)
Management of HHS
Admit
Normalise osmolality (gradually) - isotonic solution (normal saline)
IV fluid and electrolyte replacement
Normalise blood glucose (Gradually)
Medical management of diabetic neuropathy
Amitriptyline Duloxetine Gabapentin Pregabalin Topical capsaicin - may be used for localised neuropathic pain
Management of gastrointestinal autonomic neuropathy in type II diabetes
Metoclopramide
What are the diabetes sick day rules
Continue meds are normal
Increase frequency of BM monitoring
Encourage fluid intake
May need sugary drinks
Presentation of diabetic ketoacidosis
Abdominal pain Polyuria/polydipsia Dehydration Kussmaul respiration Acetone smelling breath
Management of diabetic ketoacidosis
IV Fluid replacement - isotonic saline
Fixed rate IV insulin replacement: 0.1 units/kg/hour
Correction of hypokalaemia
- if 3.5-5.5 give 40mmol/L in infusion
- if <3.5 seek senior review for additional K+
What should happen in regular insulin medication during diabetic ketoacidosis
Stop short acting
Continue long acting
What are the risks of diabetic ketoacidosis managemetnt
Arrthymias - secondary to hyperkalaemia
Cerebral oedema - secondary to fluid infusion, more common in children and needs to be closely monitored
Acute respiratory distress syndroem
AKI
What is maturity onset diabetes of the young (MODY)?
Development of type II diabetes in patients <25 years old
Typically autosomal dominant condition
Medical management of MODY
Sulfonylureas e.g, gliclizide
Features of insulinoma
Hypoglycaemia
Rapid weight gain
Raised insulin
Raised C-peptide